Influenza vaccine failure: failure to protect or failure to understand?

Introduction: I propose that influenza vaccine failure be defined as receipt of a properly stored and administered vaccine with the subsequent development of documented influenza. Several mechanisms of vaccine failure occur and can - sometimes in combination - lead to what is termed 'vaccine fa...

Full description

Saved in:
Bibliographic Details
Main Author: Gregory A. Poland (Author)
Format: Book
Published: Taylor & Francis Group, 2018-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a0fb6f77c94a4f2b88ab72b0cdfb6942
042 |a dc 
100 1 0 |a Gregory A. Poland  |e author 
245 0 0 |a Influenza vaccine failure: failure to protect or failure to understand? 
260 |b Taylor & Francis Group,   |c 2018-06-01T00:00:00Z. 
500 |a 1476-0584 
500 |a 1744-8395 
500 |a 10.1080/14760584.2018.1484284 
520 |a Introduction: I propose that influenza vaccine failure be defined as receipt of a properly stored and administered vaccine with the subsequent development of documented influenza. Several mechanisms of vaccine failure occur and can - sometimes in combination - lead to what is termed 'vaccine failure.' Influenza vaccine failure occurs for many reasons, many of which are not true failures of the vaccine (e.g. improper vaccine storage/handling). Areas covered: In this article, I discuss common causes of 'vaccine failure' that are appropriately or inappropriately attributed to vaccines. This includes host, pathogen, vaccine, and study design issues such as genetic restriction of immune response; failure to store, handle, and administer vaccine properly; issues of immunosuppression and immunosenescence; apparent but false vaccine failure; time-mediated failure; etc. Expert commentary: A proper framework and nosology for vaccine failure informs discussion about influenza vaccine efficacy and prevents misperceptions that in turn affect vaccine uptake. Influenza vaccine can only provide maximum protection to the extent that the circulating and vaccine strains closely match; the vaccine is stored, handled, and administered properly and within a time frame to result in development of protective levels of immunity; and it is administered to a host capable of immunologically responding with protective immune responses. 
546 |a EN 
690 |a vaccine storage 
690 |a immunity 
690 |a immunization programs 
690 |a influenza 
690 |a human 
690 |a influenza vaccines 
690 |a vaccination 
690 |a Internal medicine 
690 |a RC31-1245 
655 7 |a article  |2 local 
786 0 |n Expert Review of Vaccines, Vol 17, Iss 6, Pp 495-502 (2018) 
787 0 |n http://dx.doi.org/10.1080/14760584.2018.1484284 
787 0 |n https://doaj.org/toc/1476-0584 
787 0 |n https://doaj.org/toc/1744-8395 
856 4 1 |u https://doaj.org/article/a0fb6f77c94a4f2b88ab72b0cdfb6942  |z Connect to this object online.